EU regulation 528/2012 Biocidal Products Regulation (BPR) came into force in September 2013 and applies to all biocidal products. The regulation is designed to control the selling or "placing on the market" of biocidal products and involves the analysis of a products performance (efficacy), toxicity, environmental fate and risk during use. The manner in which a product is intended to be used is an important factor in BPR product assessment and products must be authorised for use in accordance with specific categories called Product Types (PTs). There are 22 different PTs ranging from PT1 "Human hygiene" through to PT22 "Embalming fluids". Ecolab's Bioquell hydrogen peroxide vapour (HPV) disinfectant - Bioquell HPV-AQ - and associated vapourisation systems have received a Union Authorisation from the European Chemicals Agency (ECHA) approval number EU-0027469-0000, which has been written into European Law under implementing regulation 2022/1226. The authorisation covers the use of the Bioquell technology in PTs 2 (Public Area), 3 (disinfection of animal cages/racks in biomedical and research facilities) and 4 (Food & Feed Areas). Biocidal products must be authorised for use within a specific PT to be marketed and used for that application - for example if a product is authorised solely for use in PT1 (Human Hygiene) applications, it cannot be used as a disinfectant for hospital surfaces, which requires a PT2 authorisation. Users should ensure that a disinfectant product or system is authorised for their specific intended use.
展开▼
